VCM
ROIV icon

Voleon Capital Management’s Roivant Sciences ROIV Stock Holding History

Voleon Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Sell
62,062
-280,359
-82% -$7.2M 0.04% 354
2025
Q4 		$7.43M Buy
342,421
+245,848
+255% +$4.85M 0.16% 135
2025
Q3 		$1.46M Buy
+96,573
New +$1.2M 0.04% 357

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voleon Capital Management's ROIV Position: Q1 2026 in Review

Voleon Capital Management reduced its Roivant Sciences (ROIV) stake by 82% in Q1 2026, selling an estimated $7.2M and leaving 62,062 shares worth $1.72M. The position accounts for 0.04% of the portfolio, ranked #354.

Voleon Capital Management first reported a position in ROIV in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.43M in Q4 2025. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Voleon Capital Management held 62,062 shares of Roivant Sciences worth $1.72M as of Q1 2026.
  • Voleon Capital Management sold 280,359 Roivant Sciences shares in Q1 2026, an estimated $7.2M.
  • Roivant Sciences made up 0.04% of Voleon Capital Management's portfolio in Q1 2026, its #354 holding.
  • Voleon Capital Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 3 quarters since.
  • Voleon Capital Management's Roivant Sciences position peaked at $7.43M in Q4 2025.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.